Gonorrhea

This module is designed to introduce student providers to the most common sexually transmitted infections (STI) in the region and indications for screening/testing. Careful consideration of patient history, current symptoms, and local STI rates will allow the student to select efficient laboratory testing to reduce time to treatment and unnecessary testing. This module will provide a basic understanding of the timing and interpretation of serological, molecular, and microscopic screening for patients who have contracted, currently or in the past, an STI.

This module is the third installment in the Sexually Transmitted Infections (STI) series and will focus on treatment of the most common treatable STIs in the United States, including syphilis, gonorrhea, chlamydia, and trichomoniasis. Students will virtually interact with simulated patients to learn how to interpret STI testing results, select the appropriate guideline-directed treatment option, and practice counseling patients regarding STI treatment. This module will help prepare students to treat patients in the RESPECT clinic and in clinical practice.

This journal examines the treatment of chlamydia and gonorrhea in primary care settings and its impact on patients' subsequent health care utilization. 

This journal presents a spatial–temporal modeling study examining how city-level sociodemographic and health-related factors influenced the prevalence of antimicrobial-resistant gonorrhea in the U.S. from 2000 to 2019. 

This  video explains Doxy PEP, a preventive option for common STDs like syphilis, gonorrhea, and chlamydia. It highlights the importance of taking doxycycline within 72 hours of potential exposure, ideally within 24 hours.

Sexually Transmitted Infections Surveillance, 2023 provides the most current and complete data for three nationally notifiable STIs: chlamydia, gonorrhea, and syphilis, including congenital syphilis.

This information guide is intended for health care professionals involved in care of persons interested in or receiving doxycycline postexposure prophylaxis (doxy PEP) for STI prevention. The information in this guide pertains to the use of doxy PEP for STI postexposure prophylaxis.

Treatment Action Group did an analysis of ongoing research in the pipeline for Gonorrhea, Chlamydia, and Syphilis. This study identified that the current toolbox for addressing gonorrhea, chlamydia, and syphilis is inadequate.